rs12138634

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.951+871T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.442 in 151,978 control chromosomes in the GnomAD database, including 15,940 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 15940 hom., cov: 31)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0730

Publications

3 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.646 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.951+871T>G intron_variant Intron 6 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.951+871T>G intron_variant Intron 6 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.951+871T>G intron_variant Intron 6 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.951+871T>G intron_variant Intron 6 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.951+871T>G intron_variant Intron 6 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.1386+871T>G intron_variant Intron 8 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.442
AC:
67166
AN:
151858
Hom.:
15912
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.286
Gnomad AMI
AF:
0.504
Gnomad AMR
AF:
0.411
Gnomad ASJ
AF:
0.531
Gnomad EAS
AF:
0.663
Gnomad SAS
AF:
0.375
Gnomad FIN
AF:
0.548
Gnomad MID
AF:
0.418
Gnomad NFE
AF:
0.512
Gnomad OTH
AF:
0.411
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.442
AC:
67243
AN:
151978
Hom.:
15940
Cov.:
31
AF XY:
0.448
AC XY:
33293
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.287
AC:
11881
AN:
41434
American (AMR)
AF:
0.410
AC:
6262
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.531
AC:
1842
AN:
3468
East Asian (EAS)
AF:
0.665
AC:
3431
AN:
5162
South Asian (SAS)
AF:
0.377
AC:
1814
AN:
4810
European-Finnish (FIN)
AF:
0.548
AC:
5781
AN:
10556
Middle Eastern (MID)
AF:
0.418
AC:
123
AN:
294
European-Non Finnish (NFE)
AF:
0.512
AC:
34772
AN:
67962
Other (OTH)
AF:
0.417
AC:
879
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1838
3676
5515
7353
9191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.474
Hom.:
6422
Bravo
AF:
0.426
Asia WGS
AF:
0.469
AC:
1634
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.9
DANN
Benign
0.68
PhyloP100
-0.073
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12138634; hg19: chr1-181550783; API